Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Building Resilient Teams: Culture Eats Strategy for Breakfast
Jamie Holcombe shares how trust, mission clarity and employee well-being help leaders build resilient teams and sustain innovation.
24m watch -
Streamlining the ATO Process Makes Software Deployments More Efficient, Secure
NIST’s Victoria Yan Pillitteri discusses common ATO stumbling blocks and how agencies can streamline authorization for secure software deployment.
7m watch -
This National Lab is Using Multi-Agent AI to Accelerate Scientific Discovery
SLAC’s John Sarrao details how AI is accelerating materials discovery and reshaping collaboration across national labs and federal agencies.
21m watch -
DOT Advisor: Federal Contracting Must Adapt to Keep Pace With AI
AI is advancing faster than federal procurement cycles, making modular contracts, AI disclosure and new pricing models increasingly critical.
11m watch
